Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Aug 1 TNDM Tandem Diabetes Care GAAP EPS of -$0.47 beats by $0.06, revenue of $221.9M beats by $16.03M
Aug 1 MRK IDeate-Lung02 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Relapsed Small Cell Lung Cancer
Jul 31 MRK Merck / Pfizer Earnings Summaries: Staying With Merck For Now, Pfizer's Cost-Cutting Will Help Margins
Jul 31 TNDM Tandem Diabetes Care Q2 2024 Earnings Preview
Jul 31 MRK Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023
Jul 31 MRK Vertex’s pain drug gets speedy FDA review; Keytruda hits a sales milestone
Jul 31 MRK Heard on the Street Tuesday Recap: Fed Purgatory
Jul 31 MRK Nasdaq Tumbles As Microsoft, Nvidia And Other Tech Stocks Decline: Greed Index Moves To 'Fear' Zone
Jul 31 MRK Q2 2024 Merck & Co Inc Earnings Call
Jul 30 OCS Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
Jul 30 MRK Merck & Co., Inc. (MRK) Q2 2024 Earnings Call Transcript
Jul 30 MRK Merck (MRK) Q2 2024 Earnings Call Transcript
Jul 30 MRK Big movers: NVIDIA slumps; P&G, Merck down, PayPal up
Jul 30 MRK Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
Jul 30 MRK Why this analyst is 'extremely bullish' on biopharma
Jul 30 MRK Merck Stock Slides on Lowered Adjusted EPS Guidance
Jul 30 MRK Merck (MRK) Q2 Earnings & Sales Beat Estimates, Cuts '24 EPS View
Jul 30 MRK Stock Market Today: Stock Market News And Analysis
Jul 30 MRK Merck Shares Fall After Drugmaker Cuts 2024 Outlook
Jul 30 MRK Merck Falls as HPV Vaccine Miss Overshadows Profit, Sales Beat
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags